AZD-2327

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameAZD-2327
Drug Alias NameAZD-2327
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionδ-opioid receptor agonists
Targetsδ-opioid receptor
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A